SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
Johnson & Johnson's business center in Switzerland
Drug Development
J&J Posts Positive Phase III Results for Carvykti and Darzalex Faspro in Multiple Myeloma Trials
Johnson & Johnson linked Carvykti to a 45% reduction in risk of death and Darzalex to a 61% improvement in minimal residual disease-negativity, boosting the prospects of two key growth drivers for the company.
September 30, 2024
 · 
2 min read
 · 
Nick Paul Taylor
Psychedelic Brain
Psychedelics
MDMA Drug Developers Reprioritize Following Lykos Rejection in PTSD
After the FDA declined to approve Lykos Therapeutics’ MDMA-assisted therapy for post-traumatic stress disorder, companies are pivoting away from or delaying similar therapeutics targeting the psychiatric disease.
September 30, 2024
 · 
5 min read
 · 
Kate Goodwin
Concept of feminism and empowerment. Feminist protest movement. Racial equality concept. Possible use for social media communication concept, blog, business between women. Chat, dialogue or communication in the workplace or between female colleagues. Interact in the virtual community. Teamwork concept. Active participation. Comparison between women or girls. Friendship. Encounter. Globalization. Multicultural and multiracial women's community. Sharing of dialogue and exchange between women of different languages and cultures
Women’s Health
IVF Restrictions, Demise of Roe v. Wade Could Endanger Women’s Health Research
Women are already underrepresented in clinical trials; the new abortion and IVF laws could make it worse.
September 30, 2024
 · 
5 min read
 · 
Aayushi Pratap
A scientist with pill bottles in front of FDA headquarters
Regulatory
FDA Action Alert: Biofrontera, BMS and Zealand
One upcoming decision—on a perioperative PD-1 regimen for lung cancer—comes as the FDA considers an overhaul of trial designs in this treatment setting.
September 30, 2024
 · 
4 min read
 · 
Tristan Manalac
East 42nd Street in New York City, Home of Pfizer Maker of Medicines and the First Approved Covid-19 Pandemic in the United States
Sickle Cell Disease
Pfizer’s Oxbryta Withdrawal Leaves Sickle Cell Community Scrambling, Investors Reeling
Pfizer’s sudden market withdrawal of sickle cell therapy Oxbryta, which some analysts predicted would reach $750 million in sales by the end of the decade, has left patients and healthcare providers with few options, while investors question the pharma giant’s dealmaking prowess.
September 27, 2024
 · 
7 min read
 · 
Annalee Armstrong
Pictured: Exterior view of the headquarters of the
FDA
Sanofi and Regeneron’s Dupixent Snags First Biologic Approval in COPD
Already approved in six indications, Sanofi and Regeneron can now add chronic obstructive pulmonary disease to the list for their blockbuster injection.
September 27, 2024
 · 
2 min read
 · 
Kate Goodwin
Polygonal human brain hemispheres gray left and rainbow color right brain engraving in top view illustration isolated on multicolor art background
Schizophrenia
FDA Approves First Novel Schizophrenia Drug in 35 Years
BMS’ KarXT targets muscarinic receptors and “is at least 2-3 years ahead of the competition” including AbbVie and Neurocrine Biosciences, Truist Securities wrote in a note to investors.
September 27, 2024
 · 
8 min read
 · 
Heather McKenzie
Editorial
Lilly Is Not ‘Feeling the Bern’ on Drug Prices Like Novo: Why the Double Standard?
Sen. Bernie Sanders’ aggressive targeting of Danish drugmaker Novo Nordisk’s Ozempic and Wegovy pricing, and not Eli Lilly’s rival drugs, is not fair.
September 27, 2024
 · 
3 min read
 · 
Greg Slabodkin
Silver Spring, MD, USA 11/10/2020: Exterior view of the headquarters of US Food and Drug Administration (FDA). This federal agency approves medications, vaccines and food additives for human use.
FDA
FDA Adcomm Recommends Limiting Keytruda, Opdivo Use in Stomach, Esophageal Cancer
The FDA’s Oncology Drugs Advisory Committee voted near-unanimously that the benefits of PD-1 inhibitors like Keytruda and Opdivo in PD-L1 low patients do not outweigh the risks.
September 27, 2024
 · 
4 min read
 · 
Heather McKenzie
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS